APYX - $100 Million Shelf Offering Filing Sends Small Cap Soaring

%ShelfOfferings (or shelf registrations as they’re sometimes called) have seem to making an appearance more frequently when sifting through headlines. This term may be new to some people, but essential it is a type of offering that allows an issuer some flexibility (time-wise) to offer securities.

According to Investopedia, “a shelf offering is a Securities and Exchange Commission (SEC) provision that allows an equity issuer (such as a corporation) to register a new issue of securities without having to sell the entire issue at once. The issuer can instead sell portions of the issue over a three-year period without re-registering the security or incurring penalties.”

Just today, it was announced that %ApyxMedical () filed for a $100 million mixed shelf. According to the release, the filing covers the sale of the company plans to use the net proceeds for working capital and other general corporate purposes.

Traders were extremely excited about the news as they snatched up shares and pushed the price up to $1.58/share (+12.86%) at the session high (at the time of writing).

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of revenue.